Holen Sie sich die Stockscreener-App
4.26
0.00%
0.00
Cryo Cell International Inc Aktie (CCEL) Neueste Nachrichten
Stem Cell/Cord Blood Banking Market Research Reveals Path To $24.47 Billion By 2030 - openPR.com
Stem Cell Umbilical Cord Blood Market Companies, Size & Trends 2026-2035 - precedenceresearch.com
Stem Cell Umbilical Cord Blood Market Size Report, 2033 - Grand View Research
Cryo-Cell (CCEL) Earnings Snapshot: The EPS Result Is Above Expectation for the Current Session; Post-Earnings: The Stock Ends Up 3.56% in Latest TradingFree Cash Flow Trends - vinanet.vn
JEXYY Stock Price and Chart — OTC:JEXYY - TradingView
CCEL Q2 2026 Earnings: EPS of $0.07 Exceeds Expectations, Stock Edges HigherSurprise Factor Analysis - Vinanet
Cell Processing Technologies Market Demonstrates Long-Term Growth Potential At 13.5% CAGR - openPR.com
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Sahm
CCEL Q2 2026 Earnings: EPS Exceeds Estimates as Shares Rally 14.25%Earnings Season Outlook - vinanet.vn
Cryo-Cell International (CCEL) Holds Flat at $3.51 Amid Tight Trading RangeOBV Breakout - dars.gov.et
Cryo-Cell International (CCEL) Slides 2.5% to $3.51 as Key Support at $3.33 LoomsOverbought Signal Alerts - Vinanet
SARO Stock Price and Chart — NYSE:SARO - TradingView
Cryo-Cell International (CCEL) moves 600,191 shares to new 2026 trust - Stock Titan
Cryo-Cell International Inc (CCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cryo-Cell International (CCEL) Holds Steady at $3.59 as Shares Approach Key ResistanceTriple EMA - dars.gov.et
Cryo-Cell International (CCEL) Gains 2.25% as Stock Holds Above Key SupportRetail Sentiment - vinanet.vn
Cryo-Cell International (CCEL) Advances 2.3%: Stem Cell Banking Stock Tests Key ResistanceETF Flow - dars.gov.et
Cryo-Cell International, Inc. Revenue Breakdown – AMEX:CCEL - TradingView
Cryo-Cell International Inc (CCEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
CCEL Q2 2026 Earnings: Positive Earnings Surprise as EPS Turns ProfitableDownward Estimate Revision - dars.gov.et
Cryo-Cell International Inc (CCEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cryo-Cell International Inc (CCEL) Balance Sheet - tradingkey.com
CCEL|Cryo-Cell International Inc|Price:3.460|Chg%:+0.040 - tradingkey.com
CCEL|Cryo-Cell International Inc|Price:3.460| - TradingKey
Cryo-Cell International Inc (CCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cryo-Cell International, Inc. Revenue Breakdown – FWB:ZCY - TradingView
Cryo-Cell International Inc (CCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cryo-Cell International (CCEL) Slips Slightly, Holds Above Key Support at $3.29Volume Gap - vinanet.vn
Cryo-Cell International Inc (CCEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cryo-Cell International Inc (CCEL) Income Statement - TradingKey
CCEL|Cryo-Cell International Inc|Price:3.600|Chg%:+0.020 - TradingKey
Cryo-Cell International (CCEL) Slips 1.14% as Stock Consolidates Near Key SupportSector ETF Flow - vinanet.vn
CCEL Q2 2026 Earnings: Positive EPS Surprise Amid Quiet Revenue DisclosureOperating Margin Analysis - vinanet.vn
Stem Cell Banking Market Size, Growth & Analysis, 2034 - Market Data Forecast
CCEL Q2 2026 Earnings: Positive EPS Surprise Amidst Operational ProgressEarnings Sentiment Score - vinanet.vn
Cryo-Cell International (CCEL) Hovers Near Support as Trading Volume Remains SubduedAnalyst Upgrade Stocks - dars.gov.et
CCEL Q2 2026 Earnings: EPS Surprises to Positive Territory Despite Stock DeclineDividend Growth Analysis - vinanet.vn
Cryo-Cell net income rises 56% to $555,000 in Q2 - scanx.trade
Cryo-Cell International Q2 Revenue USD 7.8 Million - TradingView
CCEL Reports Slight Decrease in Q2 Revenue - GuruFocus
CRYO CELL INTERNATIONAL INC Q2 2026: Revenue $7.78M (Q2), $15.46M (6 months) — 10-Q Summary - TradingView
CCEL: Revenue and net income declined, with expansion paused due to Duke arbitration and NYSE compliance risks - TradingView
[10-Q] CRYO CELL INTERNATIONAL INC Quarterly Earnings Report - Stock Titan
Tranche Update on Cryo-Cell International, Inc.'s Equity Buyback Plan announced on December 12, 2011. - marketscreener.com
Press Release: Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results - Moomoo
Cryo-Cell Intl Inc (CCEL) Debt 2025: $8.4M, down 1.5% - Stock Titan
MSN Money - MSN
OMAB Stock Price and Chart — NASDAQ:OMAB - TradingView
CCEL Q1 2026 Earnings: Surprise Profit Beat Amid Revenue UncertaintyEPS Estimate Trend - dars.gov.et
Cryo-Cell International | SCHEDULE 13D/A: Others - Moomoo
Form 13D/A CRYO CELL INTERNATIONAL INC For: 7 July By Investing.com - Investing.com Canada
Camac Fund holds 6.8% Cryo-Cell (CCEL) stake and may engage board - Stock Titan
Price to sales forward of Cryo-Cell International, Inc. – AMEX:CCEL - TradingView
CCEL Q1 2026 Earnings: Surprise Profitability as EPS Beats EstimatesRevenue Report - dars.gov.et
Cryo-Cell International (CCEL) Gains 1.83% as Momentum Builds Near SupportIchimoku Cloud - dars.gov.et
CCEL Q1 2026 Earnings: Positive EPS Surprise Marks Turnaround from Expected LossDividend Growth Analysis - dars.gov.et
Stem Cell Banking Market Size, Share, Industry Trends and Forecast 2026-2034 - openPR.com
Stem Cell Market Size, Share, Trends & Growth Report, 2033 - Market Data Forecast
World Biopreservation Media Storage EquipmentMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Cryo-Cell International, Inc. Actuals & Estimates (AMEX:CCEL) - TradingView
Cryo-Cell International (CCEL) Plunges 24.48%, Tests Critical Support at $2.75IV Rank - dars.gov.et
AMEX HALT ADD INFO LST 3.840000 - Moomoo
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
CCEL Forecast — Price Target — Prediction for 2027 - TradingView
6/26/2026 Market UpdateWinners: SDOT, BIGGQ, IVFLosers: ADTX, CELZ, TVRDS&P 500: -0.05% - Trefis
Cryo-Cell International, Inc. Actuals & Estimates (SWB:ZCY) - TradingView
ZCY Forecast — Price Target — Prediction for 2027 - TradingView
1.41%
0.86%
Kapitalisierung:
|
Volumen (24h):